Chiome’s monoclonal antibody discovery engine also includes technologies to prepare soluble proteins and membrane proteins for research, and create antibody-based multi-specific modalities.

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

To enable antibody discovery, membrane protein scientists at TetraGenetics encapsulate and stabilize purified protein in an artificial bilayer with immune-stimulating molecules to generate ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

i-Ome™ Discovery is Sengenics’ most advanced protein microarray, meticulously designed for antibody and autoantibody profiling in biomarker discovery. This powerful platform delivers key insights into ...

Membrane proteins are key targets for therapeutic intervention using antibody biologics. Over 60% of FDA-approved drugs act on these proteins. Studying them is challenging because the proteins ...

Almost 35% of drugs approved by the Food and Drug Administration work by targeting G protein-coupled receptors ... of an aGPCR extends from the cell membrane into space outside the cell, where ...

Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.